21828 articles – 15613 references  [version française]
HAL: hal-00174517, version 1

Detailed view  Export this paper
Diabetes 53, 8 (2004) 2153-7
SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts.
Delphine Eberlé 1, Karine Clément 1, 2, 3, 4, 5, David Meyre 2, Mourad Sahbatou, Martine Vaxillaire 2, Annie Le Gall 6, 7, Pascal Ferré 8, Arnaud Basdevant 5, 9, Philippe Froguel 2, 10, 11, Fabienne Foufelle
(2004-08)

Sterol regulatory element-binding protein (SREBP)-1 transcription factors play a central role in energy homeostasis by promoting glycolysis, lipogenesis, and adipogenesis. The sterol regulatory element-binding protein gene (SREBF)-1 is a good candidate gene for obesity and obesity-related metabolic traits such as type 2 diabetes and dyslipidemia. The SREBF-1 molecular screening of 40 unrelated obese patients by PCR/single-strand conformation polymorphism revealed 19 single nucleotide polymorphisms (SNPs). Six SNPs were genotyped for an association study in large French obese and nonobese cohorts. Case-control studies using two independent nonobese cohorts indicated that SNP17 (54G/C, exon 18c) is associated with morbid obesity (odds ratio 1.5, P = 0.006 and P = 0.02, respectively). SNP3 (-150G/A, exon 1a), SNP5 (-36delG, exon 1a), and SNP17 are found in high linkage disequilibrium (D' > 0.8). The haplotype including wild-type alleles of these SNPs (C/G/G/T/C/G, HAP2) is identified as a risk factor for morbid obesity (P = 0.003). In the obese group, SNP3, SNP5, and SNP17 are associated with male-specific hypertriglyceridemia (P = 0.07, P = 0.01, and P = 0.05, respectively). SNP17 is also associated with type 2 diabetes (P = 0.03) and increased prevalence of nephropathy (P = 0.028) in a diabetic cohort. Our results indicate a role of the SREBF-1 gene in genetic predisposition of metabolic diseases such as obesity, type 2 diabetes, and dyslipidemia.
1:  Déterminants Biologiques et Comportementaux des Obésités
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôtel-Dieu – Université Pierre et Marie Curie [UPMC] - Paris VI – EA3502
2:  Génétique des maladies multifactorielles (GMM)
CNRS : UMR8090 – Université Lille II - Droit et santé
3:  Service de nutrition
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôpital de l'Hôtel-Dieu
4:  Nutrition et obésité : approches génétique et transcriptomique
INSERM : U755 – IFR58 – Université Pierre et Marie Curie [UPMC] - Paris VI
5:  Département de nutrition
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôtel-Dieu
6:  Géosciences Rennes (GR)
CNRS : UMR6118 – INSU – Centre Armoricain de Recherches en Environnement – Université de Rennes 1
7:  Centre d'étude des environnements terrestre et planétaires (CETP)
CNRS : UMR8639 – INSU – Université de Versailles Saint-Quentin-en-Yvelines
8:  Pathologies nutritionnelles et métaboliques : obésité et diabète
INSERM : U671 – IFR58 – Université Pierre et Marie Curie [UPMC] - Paris VI
9:  Laboratoire de Probabilités et Modèles Aléatoires (LPMA)
CNRS : UMR7599 – Université Pierre et Marie Curie [UPMC] - Paris VI – Université Paris VII - Paris Diderot
10:  Section of Genomic Medicine
Imperial College
11:  Genome Centre
Imperial College London – Hammersmith campus
Life Sciences/Genetics/Human genetics